High glucose treatment promotes extracellular matrix proteome remodeling in Muller glial cells.
PeerJ 9:e11316 (2021)
Background. The underlying pathomechanisms in diabetic retinopathy (DR) remain incompletely understood. The aim of this study was to add to the current knowledge about the particular role of retinal Muller glial cells (RMG) in the initial processes of DR.Methods. Applying a quantitative proteomic workflow, we investigated changes of primary porcine RMG under short term high glucose treatment as well as glycolysis inhibition treatment.Results. We revealed significant changes in RMG proteome primarily in proteins building the extracellular matrix (ECM) indicating fundamental remodeling processes of ECM as novel rapid response to high glucose treatment. Among others, Osteopontin (SPP1) as well as its interacting integrins were significantly downregulated and organotypic retinal explant culture confirmed the selective loss of SPP1 in RMG upon treatment. Since SPP1 in the retina has been described neuroprotective for photoreceptors and functions against experimentally induced cell swelling, it's rapid loss under diabetic conditions may point to a direct involvement of RMG to the early neurodegenerative processes driving DR. Data are available via ProteomeXchange with identifier PXDO15879.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Diabetic Retinopathy ; Secreted Phosphoprotein 1 (spp1) ; Osteopontin ; Neurodegeneration ; Organotypic Explant Cultures ; Translational Large Animal Model ; Pig; Data-independent Acquisition; Diabetic-retinopathy; Identification; Proteins; Survival; Cultures; Retina; Edema; Model
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
2167-8359
e-ISSN
2167-8359
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 9,
Heft: ,
Seiten: ,
Artikelnummer: e11316
Supplement: ,
Reihe
Verlag
PeerJ
Verlagsort
341-345 Old St, Third Flr, London, Ec1v 9ll, England
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-505700-001
A-630700-001
Förderungen
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2021-06-23